Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Antibodies to beta2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor.

Salemink I, Blezer R, Willems GM, Galli M, Bevers E, Lindhout T.

Thromb Haemost. 2000 Oct;84(4):653-6.

PMID:
11057865
3.

Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity.

Salemink I, Franssen J, Willems GM, Hemker HC, Li A, Wun TC, Lindhout T.

Thromb Haemost. 1998 Aug;80(2):273-80.

PMID:
9716152
4.

Transient high affinity binding of tissue factor pathway inhibitor-factor Xa complexes to negatively charged phospholipid membranes.

Willems GM, Janssen MP, Salemink I, Wun TC, Lindhout T.

Biochemistry. 1998 Mar 10;37(10):3321-8.

PMID:
9521652
5.

Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.

Franssen J, Salemink I, Willems GM, Wun TC, Hemker HC, Lindhout T.

Biochem J. 1997 Apr 1;323 ( Pt 1):33-7.

6.

Tissue factor pathway inhibitor: regulation of its inhibitory activity by phospholipid surfaces.

Lindhout T, Salemink I, Valentin S, Willems GM.

Haemostasis. 1996 Oct;26 Suppl 4:89-97. Review.

PMID:
8979115
7.
8.

delta-Crystallin is more thermostable than mammalian argininosuccinate lyase.

Voorter CE, Salemink I, De Jong WW.

Exp Eye Res. 1993 Jun;56(6):733-5. No abstract available.

PMID:
8595816

Supplemental Content

Loading ...
Support Center